# Regulatory Standard Mapping for MedTech

*/Opportunities/Regulatory_Standard_Mapping_for_MedTech*

## Opportunity Overview

**Wedge**: The beachhead is EU MDR recertification mapping for existing Class IIa and IIb medical devices. This specific niche faces a hard, immovable regulatory deadline requiring massive documentation rework, creating acute pain and immediate budget allocation. After winning the EU MDR mapping use case, the product expands horizontally to map those same ingested design files to FDA 510(k) requirements and ISO 14971 risk management standards.
**Timing**: Large context window models now accurately parse dense, multi-hundred-page technical design dossiers and cross-reference them against highly technical regulatory codes without losing logical threading. Simultaneously, the strict transition to the EU Medical Device Regulation (MDR) creates an immediate backlog of recertification documentation that regulatory teams cannot clear manually.
**Why This I C P**: Mid-market MedTech companies with $50M to $500M in revenue face the exact same stringent regulatory requirements as industry giants but lack armies of in-house regulatory affairs personnel. They rely heavily on expensive external consultants for market access, making them highly motivated to adopt tools that directly replace hourly consulting fees.
**Size Of Prize**: Approximately 6,500 active MedTech manufacturers globally managing Class II and III devices spend an average of $60,000 annually on external regulatory mapping consultants and manual audit preparation. This yields an addressable economic prize of roughly $390M for automated standard mapping.
**Gap Narrative**: MedTech manufacturers spend thousands of hours manually cross-referencing design history files and technical documentation against shifting global regulatory standards. Existing compliance software acts as a static repository rather than an active parsing engine that maps specific engineering claims to specific regulatory clauses. This leaves a gap for a system that reads technical files and automatically highlights missing or non-compliant evidence against target regulations.
**Defensibility**: Defensibility stems from proprietary data accumulation and workflow lock-in. As the system maps thousands of accepted technical files to specific clauses, it builds a proprietary graph of what evidence auditors consistently accept or reject for specific device types. Once a manufacturer hosts its core traceability matrices on the platform, the switching cost of migrating that dynamic compliance evidence to another system becomes prohibitively high.
**Why This Thesis**: A Service-as-Software approach directly consumes the raw technical files and outputs the finished traceability matrix, replacing the service previously bought from consultants. Instead of selling a workflow tool that the understaffed regulatory team must still operate, the product delivers the completed regulatory mapping artifact.

## Opportunity Linked Thesis

**Thesis**: [Software](/Theses/Software)

## Opportunity Linked I C P

**Icp**: [Medical Device Manufacturer](/CompanyTypes/Medical_Device_Manufacturer)

## Opportunity Market Sizing

_Illustrative — target and order-of-magnitude estimate figures, not an achieved track record (this Thing is concept-stage)._

**S A M**: ~$300-750M (US and EU mid-market to enterprise MedTech firms actively managing FDA/MDR compliance)
**S O M**: ~$15-50M
**T A M**: ~30k global medical device manufacturers × ~$30k-50k/yr compliance software and mapping spend ≈ ~$900M-1.5B
**Growth Rate**: ~12-18%/yr, driven by stringent EU MDR transition requirements and expanding FDA frameworks for software and AI devices
**Paid Comparable Spend**: ~$50k-150k/yr per firm spent on external regulatory affairs consultants, manual gap analysis labor, and generic QMS modules

## Opportunity Incumbents

- [Greenlight Guru](/Products/Greenlight_Guru) — Tool
- [Matrix Requirements](/Products/Matrix_Requirements) — Tool
- [Compliance Matrix Spreadsheets](/Products/Compliance_Matrix_Spreadsheets) — Spreadsheet
- [Regulatory Consultants](/Products/Regulatory_Consultants) — Service
- [Veeva Vault MedTech](/Products/Veeva_Vault_MedTech) — Tool
- [BSI Compliance Navigator](/Products/BSI_Compliance_Navigator) — Tool
- [Arena QMS](/Products/Arena_QMS) — Tool

## Opportunity Win Conditions

**Kill Thresholds**:
- Clause mapping accuracy remains < 85% after 30 days of tuning
- User overrides > 30% of auto-mapped requirements
- Pilot-to-paid conversion rate < 20% after 90 days
- Sales cycle exceeds 120 days for mid-market accounts
**Leading Metrics**:
- Clause auto-mapping accuracy rate
- Time-to-first gap analysis report
- Human override percentage per uploaded document
- Weekly active days per Regulatory Affairs user
**What Proves Right**: Regulatory affairs managers upload existing technical files and the system maps over 85 percent of clauses to EU MDR or FDA requirements without manual intervention. Customers pay a $25k+ annual contract after a successful pilot because the tool eliminates the need for external gap analysis consultants. Cohort retention exceeds 90 percent as regulations update and the system automatically flags affected documentation.
**What Proves Wrong**: The mapping accuracy falls below 70 percent, forcing regulatory teams to manually review every clause and defeating the time-saving value proposition. Companies refuse to adopt the tool because it fails to export cleanly into entrenched QMS platforms like Greenlight Guru or Veeva Vault. The sales cycle stretches past 6 months due to compliance teams distrusting automated gap analyses.

## Opportunity Build Profile

**Hardest Part**: Achieving zero-hallucination semantic matching between highly technical regulatory clauses and fragmented internal engineering documents where missing a single requirement triggers an audit failure.
**Min Viable Scope**: Focus exclusively on mapping Software as a Medical Device products to FDA 21 CFR Part 820 and ISO 13485. Deliberately exclude hardware devices, EU MDR compliance, clinical trial documentation, and automated document generation.
**Cold Start Problem**: The system requires validated mappings of proprietary company documents to standard clauses to train the model, but MedTech firms tightly guard their compliance data. Break this by partnering with regulatory compliance consultancies to ingest their anonymized historical audit gap analyses as the initial baseline.
**Time To First Value**: 2-4 weeks of document ingestion and indexing
**Data Moat Available**: true
**Technical Difficulty**: High

## Neighborhood

### Incumbent in

- [Veeva Vault MedTech](/Products/Veeva_Vault_MedTech) — incumbent in · Products
- [Matrix Requirements](/Products/Matrix_Requirements) — incumbent in · Products
- [Regulatory Consultants](/Products/Regulatory_Consultants) — incumbent in · Products
- [Arena QMS](/Products/Arena_QMS) — incumbent in · Products
- [BSI Compliance Navigator](/Products/BSI_Compliance_Navigator) — incumbent in · Products
- [Compliance Matrix Spreadsheets](/Products/Compliance_Matrix_Spreadsheets) — incumbent in · Products
- [Greenlight Guru](/Products/Greenlight_Guru) — incumbent in · Products

### Applies thesis

- [Medical Device Manufacturer](/CompanyTypes/Medical_Device_Manufacturer) — applies thesis · CompanyTypes

### Embodies

- [Software](/Theses/Software) — embodies · Theses

### Similar Opportunities

- [Autonomous Dossier Compilation for Hardware](/Opportunities/Autonomous_Dossier_Compilation_for_Hardware) — similar · Opportunities
- [Certification Audit Service](/Metrics/Requirements_Traceability_Index/Opportunities/Certification_Audit_Service) — similar · Opportunities
- [Certification Dossier Service](/Opportunities/Certification_Dossier_Service) — similar · Opportunities
- [Requirements Impact Engine](/Metrics/Requirements_Traceability_Index/Processes/Requirements_Management/Opportunities/Requirements_Impact_Engine) — similar · Opportunities
- [Clinical Evidence Compiler](/Opportunities/Clinical_Evidence_Compiler) — similar · Opportunities
- [Managed Validation Service](/Metrics/Requirements_Traceability_Index/Processes/Verification_And_Validation/Opportunities/Managed_Validation_Service) — similar · Opportunities
- [Certification Dossier Service](/Knowledge/Engineering_and_Technology/Opportunities/Certification_Dossier_Service) — similar · Opportunities
- [Critical Requirement Gating](/Metrics/Requirements_Traceability_Index/Processes/Software_Testing/Opportunities/Critical_Requirement_Gating) — similar · Opportunities
- [Traceability Matrix Generator](/Metrics/Requirements_Traceability_Index/Opportunities/Traceability_Matrix_Generator) — similar · Opportunities
- [Polymer Traceability For Medtech](/Opportunities/Polymer_Traceability_For_Medtech) — similar · Opportunities
- [AI Regulatory Mapping](/Opportunities/AI_Regulatory_Mapping) — similar · Opportunities
- [Architecture Impact Analyzer](/Metrics/Requirements_Traceability_Index/Opportunities/Architecture_Impact_Analyzer) — similar · Opportunities
- [Automated Evidence Mapping](/Opportunities/Automated_Evidence_Mapping) — similar · Opportunities
- [Vendor Compliance Audits](/Opportunities/Vendor_Compliance_Audits) — similar · Opportunities
- [Compliance Reporting Automation](/Opportunities/Compliance_Reporting_Automation) — similar · Opportunities
- [Continuous Evidence Gateway](/Metrics/Requirements_Traceability_Index/Processes/Compliance_Auditing/Opportunities/Continuous_Evidence_Gateway) — similar · Opportunities
- [Autonomous Dossier Structuring for Pharma](/Opportunities/Autonomous_Dossier_Structuring_for_Pharma) — similar · Opportunities
- [Continuous Audit Compliance](/Opportunities/Continuous_Audit_Compliance) — similar · Opportunities
- [Compliance as a Service](/Opportunities/Compliance_as_a_Service) — similar · Opportunities
- [Continuous Compliance Auditor](/Industries/Health_Care_and_Social_Assistance/Opportunities/Continuous_Compliance_Auditor) — similar · Opportunities